Cardiac electrophysiology

Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

Retrieved on: 
星期二, 六月 4, 2024
Mount Sinai Health System, News, FACC, Patient, Atlanta (magazine), Interventional cardiology, Arrhythmia, Physician, Cardiovascular disease, Cardiology, Cardiac electrophysiology, Mount Sinai Hospital, Tachycardia, Internal medicine, Moyamoya disease, Atrial fibrillation, Medical device

Dr. Reddy’s pioneering clinical research is changing the way cardiac patients are treated and cured.

Key Points: 
  • Dr. Reddy’s pioneering clinical research is changing the way cardiac patients are treated and cured.
  • Under his leadership, Mount Sinai is the lead site on several multinational clinical trials exploring new arrhythmia procedures and technologies.
  • In 2014, Dr. Reddy implanted the world’s first miniature leadless pacemaker in a patient’s heart in the United States at The Mount Sinai Hospital.
  • A live question and answer session will follow formal presentations.

Joyce University Announces New Leadership in Nursing and Health Sciences

Retrieved on: 
星期四, 五月 30, 2024
Nursing, Education, Health, Continuing, Training, University, Timpanogos Regional Hospital, Learning, Commission, Strategic planning, Bachelor, CCNE, Dean (education), Cardiac catheterization, Outline of health sciences, Assistant, Growth, Student, NWCCU, Associate, Nursing care plan, Curriculum, Communication, Employment, Cardiac electrophysiology, General Education, Multimedia, ACEN, OTA

She brings over 30 years of nursing experience and 15 years of experience in nursing education, having served as Dean and Regional Dean for several years at her previous university.

Key Points: 
  • She brings over 30 years of nursing experience and 15 years of experience in nursing education, having served as Dean and Regional Dean for several years at her previous university.
  • Jennifer Ayotte joins Joyce University as the new Dean of General Education and Health Sciences.
  • Since joining Joyce University in 2020, Winter has demonstrated exceptional leadership as Assistant Director of Capstone and Program Chair of Nursing Clinical Education.
  • Founded in 1979, Joyce University of Nursing and Health Sciences’ mission is to prepare students to serve as competent professionals, to advance their careers, and to pursue lifelong learning.

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment

Retrieved on: 
星期三, 五月 29, 2024
Penn Presbyterian Medical Center, Patient, Arrhythmia, Health, Risk, Robotics, Heart failure, University, Arrest, Safety, Stroke, Cardiac electrophysiology, Anatomy, Robotic magnetic navigation, Medical device

Genesis is the latest advancement in Robotic Magnetic Navigation technology.

Key Points: 
  • Genesis is the latest advancement in Robotic Magnetic Navigation technology.
  • Robotic Magnetic Navigation introduces the benefits of robotic precision and safety to cardiac ablation, a common minimally invasive procedure to treat arrhythmias.
  • “Our adoption of advanced robotic technology significant enhances our ability to precisely diagnose and treat patients suffering from complex cardiac arrhythmias,” said Dr. Benjamin D’Souza, Cardiac Electrophysiologist at Penn Presbyterian Medical Center.
  • “We look forward to supporting Penn Presbyterian in growing a highly successful and impactful robotic heart care program that advances patient care, clinical research and technology advancement.”

Mario Lemieux Foundation, Highmark Health Announce Major Gift to AHN Cardiovascular Institute, Establishing "The Mario Lemieux Center for Heart Rhythm Care"

Retrieved on: 
星期五, 五月 10, 2024
Hockey, Patient, Data collection, Cardiovascular disease, Faculty, Chair, American Heart Association, Risk, Palpitations, Machine learning, Heart, Education, Cardiac electrophysiology, AHN, Stroke, Ventricular fibrillation, Death, Research, Atrial fibrillation, AGH, Fatigue, Artificial intelligence, EP, Joint, American College, Joint Commission, Disability, Cardiology, Pharmaceutical industry

PITTSBURGH, May 10, 2024 /PRNewswire/ -- Representatives from the Mario Lemieux Foundation and Highmark Health today announced a major collaborative gift to Allegheny Health Network's (AHN) Cardiovascular Institute that will further strengthen the organization's nationally recognized cardiac electrophysiology (EP) program. The joint commitment, totaling $5 million, will formally establish "The Mario Lemieux Center for Heart Rhythm Care" at AHN.

Key Points: 
  • The joint commitment, totaling $5 million, will formally establish "The Mario Lemieux Center for Heart Rhythm Care" at AHN.
  • Lemieux Foundation, Highmark Health Announce Major Gift to AHN, Establish The Mario Lemieux Center for Heart Rhythm Care
    This is the second philanthropic gift to AHN's EP program from the Mario Lemieux Foundation.
  • In 2019, the Foundation created the "Mario Lemieux Innovation and Research Fund" through a $1 million gift, which also was matched by Highmark Health.
  • In 2005, hockey legend Mario Lemieux was diagnosed with atrial fibrillation (AFib), the most prevalent heart rhythm disorder in the country.

Field Medical Announces First-in-Human Trials for Groundbreaking FieldForce™ Ventricular Pulsed Field Ablation Technology

Retrieved on: 
星期四, 五月 9, 2024
PFA, Physics, Safety, Arrhythmia, Catheter ablation, HRS, PVC, MD, Cardiac electrophysiology, Workflow, Mount Sinai Health System, Ventricular tachycardia, Cardiac cycle, Patient, Atrial fibrillation, Boston Scientific, Medical device

CARDIFF-BY-THE-SEA, Calif., May 9, 2024 /PRNewswire/ -- Field Medical,™ Inc., a pioneer in pulsed field cardiac catheter ablation technology, today announced the initiation of its first-in-human study for the FieldForce™ Ablation System at Na Homolce Hospital in Prague, Czech Republic. The Ventricular Catheter Ablation Study, VCAS, will enroll up to 60 patients at up to 5 sites world-wide. The VCAS investigational study is a critical step towards demonstrating safety and performance of the FieldForce™ Ablation System, developed specifically to address the limitations of existing pulsed field ablation (PFA) and radiofrequency (RF) ablation systems, including a more time efficient treatment protocol for the treatment of ventricular arrhythmias. Preliminary results will be presented on May 16, 2024, at the Heart Rhythm Scientific Sessions in Boston, Mass.

Key Points: 
  • First and only contact force pulsed field ablation (PFA) system designed to transform treatment for millions with life-threatening ventricular arrhythmias.
  • CARDIFF-BY-THE-SEA, Calif., May 9, 2024 /PRNewswire/ -- Field Medical,™ Inc., a pioneer in pulsed field cardiac catheter ablation technology, today announced the initiation of its first-in-human study for the FieldForce™ Ablation System at Na Homolce Hospital in Prague, Czech Republic.
  • The Ventricular Catheter Ablation Study, VCAS , will enroll up to 60 patients at up to 5 sites world-wide.
  • Current ventricular catheter ablation methods involve lengthy procedures and significant risks associated with thermal ablation, like conventional RF ablation.

Field Medical Announces First-in-Human Trials for Groundbreaking FieldForce™ Ventricular Pulsed Field Ablation Technology

Retrieved on: 
星期四, 五月 9, 2024
PFA, Physics, Safety, Arrhythmia, Catheter ablation, HRS, PVC, MD, Cardiac electrophysiology, Workflow, Mount Sinai Health System, Ventricular tachycardia, Cardiac cycle, Patient, Atrial fibrillation, Boston Scientific, Medical device

CARDIFF-BY-THE-SEA, Calif., May 9, 2024 /PRNewswire/ -- Field Medical,™ Inc., a pioneer in pulsed field cardiac catheter ablation technology, today announced the initiation of its first-in-human study for the FieldForce™ Ablation System at Na Homolce Hospital in Prague, Czech Republic. The Ventricular Catheter Ablation Study, VCAS, will enroll up to 60 patients at up to 5 sites world-wide. The VCAS investigational study is a critical step towards demonstrating safety and performance of the FieldForce™ Ablation System, developed specifically to address the limitations of existing pulsed field ablation (PFA) and radiofrequency (RF) ablation systems, including a more time efficient treatment protocol for the treatment of ventricular arrhythmias. Preliminary results will be presented on May 16, 2024, at the Heart Rhythm Scientific Sessions in Boston, Mass.

Key Points: 
  • First and only contact force pulsed field ablation (PFA) system designed to transform treatment for millions with life-threatening ventricular arrhythmias.
  • CARDIFF-BY-THE-SEA, Calif., May 9, 2024 /PRNewswire/ -- Field Medical,™ Inc., a pioneer in pulsed field cardiac catheter ablation technology, today announced the initiation of its first-in-human study for the FieldForce™ Ablation System at Na Homolce Hospital in Prague, Czech Republic.
  • The Ventricular Catheter Ablation Study, VCAS , will enroll up to 60 patients at up to 5 sites world-wide.
  • Current ventricular catheter ablation methods involve lengthy procedures and significant risks associated with thermal ablation, like conventional RF ablation.

MarinHealth Medical Center Becomes First Hospital in Northern California to Successfully Implant AVEIR™ DR, the World’s First Dual Chamber Leadless Pacemaker System

Retrieved on: 
星期五, 四月 5, 2024
Cardiology, Biotechnology, Surgery, General Health, Health, Medical Devices, Hospitals, Health Technology, VR, Communication, Infection, Atrial fibrillation, Risk, Immunosuppression, Patient, Cardiac electrophysiology, MD, Life, Stroke, Leg, Engineering, Heart, Dialysis, San Francisco Bay Area, FDA, Food, Medical device

MarinHealth Medical Center today announced the successful implantation of an AVEIR™ DR pacemaker system, becoming the first hospital in Northern California to insert the world’s first dual chamber leadless pacemaker system.

Key Points: 
  • MarinHealth Medical Center today announced the successful implantation of an AVEIR™ DR pacemaker system, becoming the first hospital in Northern California to insert the world’s first dual chamber leadless pacemaker system.
  • “MarinHealth is proud to be at the forefront in the clinical care of heart rhythm disorders.
  • Now, we are excited to become the first center in Northern California to offer dual chamber leadless pacemaker technology, which provides yet another state-of-the-art solution for heart rhythm patients in our community,” said Anita Chandrasena, MD , Chief Medical Officer of MarinHealth.
  • Roughly one-tenth the size of a traditional pacemaker, the dual chamber AVEIR leadless pacing system is made up of two devices: a ventricular (VR) and an atrial (AR) leadless pacemaker.

Texas Cardiac Arrhythmia Institute at St. David's Medical Center to host international conference on complex cardiac arrhythmias

Retrieved on: 
星期二, 三月 26, 2024
Arrhythmia, American Medical Association, St Davids, University of Pennsylvania, Mount Sinai Hospital, MedStar Health, Patient, PFA, Electrophysiology, University, LAA, Medical Center, Cleveland Clinic, Atrial fibrillation, Ventricular tachycardia, Physician, Cardiac electrophysiology, Vancouver General Hospital, PRA

AUSTIN, Texas, March 26, 2024 /PRNewswire/ -- On April 18 and 19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center will host its seventh international symposium on complex arrhythmias, EPLive 2024.

Key Points: 
  • AUSTIN, Texas, March 26, 2024 /PRNewswire/ -- On April 18 and 19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center will host its seventh international symposium on complex arrhythmias, EPLive 2024.
  • Live cases, which are broadcast with expert commentary from the state-of-the-art Electrophysiology Center at St. David's Medical Center, will serve as the primary teaching tool.
  • The Texas Cardiac Arrhythmia Institute features the leading robotic electrophysiology center in North America.
  • The 72,000-square-foot center, which opened in 2019, includes six electrophysiology labs equipped with advanced technology for treatment of complex arrhythmias.

Texas Cardiac Arrhythmia Institute at St. David's Medical Center to host international conference on complex cardiac arrhythmias

Retrieved on: 
星期二, 三月 26, 2024
Arrhythmia, American Medical Association, St Davids, University of Pennsylvania, Mount Sinai Hospital, MedStar Health, Patient, PFA, Electrophysiology, University, LAA, Medical Center, Cleveland Clinic, Atrial fibrillation, Ventricular tachycardia, Physician, Cardiac electrophysiology, Vancouver General Hospital, PRA

AUSTIN, Texas, March 26, 2024 /PRNewswire/ -- On April 18 and 19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center will host its seventh international symposium on complex arrhythmias, EPLive 2024.

Key Points: 
  • AUSTIN, Texas, March 26, 2024 /PRNewswire/ -- On April 18 and 19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center will host its seventh international symposium on complex arrhythmias, EPLive 2024.
  • Live cases, which are broadcast with expert commentary from the state-of-the-art Electrophysiology Center at St. David's Medical Center, will serve as the primary teaching tool.
  • The Texas Cardiac Arrhythmia Institute features the leading robotic electrophysiology center in North America.
  • The 72,000-square-foot center, which opened in 2019, includes six electrophysiology labs equipped with advanced technology for treatment of complex arrhythmias.

PrepMD and Magnifi Group Launch Annual EP Course for Fellows and Young Attendings

Retrieved on: 
星期五, 三月 22, 2024
Partnership, History, MD, EP, Wolpe, Cardiac electrophysiology, Nursing

BRAINTREE, Mass., March 22, 2024 /PRNewswire/ -- PrepMD, the leading provider of cardiac healthcare solutions, and Magnifi Group, Inc., renowned for its educational courses for Orthopedic Fellows, today announced partnership to create and manage an innovative annual Electrophysiology (EP) Fellows and Young EP Attendings course .

Key Points: 
  • BRAINTREE, Mass., March 22, 2024 /PRNewswire/ -- PrepMD, the leading provider of cardiac healthcare solutions, and Magnifi Group, Inc., renowned for its educational courses for Orthopedic Fellows, today announced partnership to create and manage an innovative annual Electrophysiology (EP) Fellows and Young EP Attendings course .
  • Renowned Electrophysiologist Vivek Reddy, MD will lead the course, supported by an estimated ten distinguished EP specialists.
  • Andrew Wolpe, President/COO of Magnifi Group, anticipates a promising launch of the EP Fellows Program with PrepMD's collaboration.
  • It is available to 2nd-year EP fellows and 1st and 2nd-year attendings, with limited spots for 55 attendees.